Astellas Deutschland Gmbh

Thomas Alfred Profitlich

Jeffrey Colledge

Margaretha Olthoff

Ulrich Patzak

Taoufik Ouatas

In the present invention there is provided a pharmaceutical composition in a solid dosage form suitable or oral administration, the composition comprising bendamustine or a pharmaceutically acceptable ester, salt or solvate thereof as an active ingredient, and at least one pharmaceutically acceptable excipient, which is a pharmaceutically acceptable saccharide selected from the group consisting of one or more of a monosaccharide, a disaccharide, an oligosaccharide, a cyclic oligosaccharide, a polysaccharide and a saccharide alcohol, wherein the ratio by weight of the active ingredient to the saccharide excipient(s) is in the range of 1:1-5.

Growing community of inventors

Leiderdorp, Netherlands

Thomas Alfred Profitlich